Articles: treatment.
-
Moxibustion is an ancient Traditional Chinese Medicine practice used to treat a variety of symptoms and medical conditions. Here we present the case of an elderly patient whose scars from prior moxibustion treatment were initially misdiagnosed as digital ischemia.
-
Dural arteriovenous fistulas (DAVFs) of the falx cerebri are extremely rare and may be associated with the falcine sinus. The distal dural supply from the anterior cerebral artery (ACA) comes via the pericallosal artery. ⋯ DAVF in the falx cerebri solely supplied by the distal dural supply of the ACA may be more suitable for surgical treatment rather than endovascular therapy. We herein describe a rare case of DAVF in the falx cerebri solely supplied by the distal dural supply of the ACA, which was treated with surgical ligation of the draining vein.
-
Balantidium coli is the largest, uncommon, and only ciliate parasite that infects humans and is more common in tropics and subtropical regions. It is mostly asymptomatic, but can cause diarrhea and abdominal pain and sometimes leads to perforation of the colon. It is harbored in animals, particularly among pigs in hotter environments and monkeys in the jungles. ⋯ Retrieval of rare parasites was possible only because of prompt stool transport and its early processing. There are only few previous reports regarding the pediatric cases of balantidiasis, and there is a little information about its clinical signs and treatment. Here, we report a case series of B. coli infection presenting as an acute diarrheal disease from Rajasthan.
-
Chimeric antigen receptor (CAR) T cells are T lymphocytes that are genetically engineered to express a synthetic receptor that recognizes a tumor cell surface antigen and causes the T cell to kill the tumor cell. CAR T treatments improve overall survival for patients with large B-cell lymphoma and progression-free survival for patients with multiple myeloma. ⋯ CAR T-cell therapy is an FDA-approved therapy that has improved progression-free survival for multiple myeloma, improved overall survival for large B-cell lymphoma, and attained high rates of cancer remission for other hematologic malignancies such as acute lymphoblastic leukemia, follicular lymphoma, and mantle cell lymphoma. Recently approved T lymphocyte-based therapies demonstrated the potential for improved outcomes in solid tumor malignancies.